Evolution and comparison of arteriovenous passage times (AVT) in patients with RVO over 12 months
| Group | AVT D0 | AVT M6 | M6/D0* p value | AVT M12 | M12/D0† p value |
|---|---|---|---|---|---|
| Data expressed as mean (SD). | |||||
| *Wilcoxon signed rank sum test comparing AVT M6 to AVT D0 and †comparing AVT M12 to AVT D0 within each group (subjects lost to follow up were excluded). | |||||
| NICRVO = non-ischaemic central retinal vein occlusion; ICRVO = ischaemic retinal vein occlusion; BRVO = branch retinal vein occlusion; AVT = arteriovenous passage time measured by fluorescein angiography in seconds; D0 = day of admission; M6 = 6 months later; M12 = 12 months later. | |||||
| NICRVO | 14.27 (4.23) (51) | 10.82 (3.04) (44) | 0.0001 | 10.79 (3.70) (39) | 0.0002 |
| ICRVO | 17.89 (3.84) (18) | 14.69 (5.11) (16) | 0.013 | 16.06 (6.07) (16) | 0.607 |
| BRVO | 13.06 (4.17) (32) | 10.52 (3.06) (25) | 0.011 | 10.36 (2.41) (25) | 0.0009 |